SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899923-22-000096
Filing Date
2022-06-30
Accepted
2022-06-29 18:28:29
Documents
12
Period of Report
2022-06-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20220628.htm   iXBRL 8-K 33172
  Complete submission text file 0000899923-22-000096.txt   167071

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20220628.xsd EX-101.SCH 1884
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20220628_lab.xml EX-101.LAB 23832
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20220628_pre.xml EX-101.PRE 12496
6 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20220628_htm.xml XML 10810
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 221056006
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences